VitalQuant recruits Strategy Designers from respected Wall Street investment firms (these companies haven't endorsed VitalQuant):
The Turbo Microcaps Strategy by VitalQuant is an evidence-based quantitative framework aimed at capturing the exceptional returns often found in the most overlooked segment of the equity market. This strategy focuses on microcap stocks—companies valued between $100 million and $400 million—that are typically ignored by institutional analysts and large-scale funds because of their small size and liquidity.
Utilizing a systematic “quality-adjusted” approach, the strategy filters out speculative or low-quality companies to identify high-conviction growth opportunities. By leveraging key factors such as valuation, momentum, and financial stability, Turbo Microcaps seeks to exploit market inefficiencies and information arbitrage, ultimately aiming to achieve significant long-term outperformance with an annual return of 85%+.
In the world of institutional investing, "size" is often a handicap. Large funds with billions of dollars can’t touch micro-cap and small-cap stocks because their entry would significantly move the price, destroying any edge. This creates a massive inefficiency that individual investors and boutique firms can exploit in this segment of thre market.
The Turbo Microcaps Strategy turns this inefficiency into a systematic advantage. Unfortunately, we must limit the number of subscribers and the amount of money that can access this system.
1. Mathematical Dominance
Since 2019, this strategy has delivered an Annual Return of 85%+. To put that in perspective, while the broader markets celebrate years with gains of 15%, this strategy has consistently sought out the huge winning investments that grow your portfolio five-times as fast, hidden in the microcap range of the stock market.
2. Institutional-Grade Risk Management
High returns usually come with stomach-churning volatility. However, our ranking factors are specifically tuned to identify stable, fundamentally sound companies. Then, when we apply our sophisticated Vital Risk Control™ technology to the strategy, returns shoot skyward because stocks no longer need to make up for significant losses. You can sleep soundly knowing your downside is limited by a system proven in live operation.
Maximum Drawdown: The worst single drawdown since inception was only -17%. Win Rate: about 59% of all trades are profitable.
Precision: We don’t "buy and hope." We hold for an average of 24 days (1.14 months), moving capital quickly into the highest-potential setups to keep your money consistently working.
3. The "Triple-Threat" Filter
Our proprietary algorithms don't just look at a chart.
Every Sunday, it re-ranks the micro-cap universe based on fundamentals:
Value: Identifying stocks trading well below their intrinsic worth.
Stability: Filtering out "penny stock" volatility in favor of real balance sheets.
Velocity: Targeting companies with the highest growth rates in their respective sectors, and the highest growth rates of their fundamental factors.
Own the five small companies that will explode higher in the coming weeks and months...
Because this model operates in the micro-cap space, liquidity is finite. We cannot allow hundreds of subscribers to buy the same $100 million company without artificially inflating prices and destroying the strategy’s edge.
To protect the integrity of the returns for our existing users, we must strictly limit the amount of money invested in the positions of this model. Because of this liquidity restriction, we have limited the number of subscribers to approximately 10. Because of its very limited subscriber capacity, there is a $5,000 setup fee and subscriptions cost $1,997 per month.
Once we hit the cap of 8-12 subscribers, the doors will close, and a waiting list will be established. If you see the waiting list form when you try to subscribe to this model, please enter your contact info and an accurate estimate of your portfolio size. We will contact you when an opening for that portfolio size becomes available.
Please don't try to game the system by entering a smaller-than-actual size portfolio. In selecting subscribers, we are effectively filling in the openings in a jigsaw puzzle. If your portfolio isn't the right size, it won't be selected. In addition, if you state a smaller-than-actual portfolio size and you actually invest much more, you risk having your subscription terminated because we see that adding your subscription is moving the prices of the positions. It's in your, our, and your fellow subscriber's best interest to be honest in regards to your portfolio size.
You may wish to select a different model if there is a waiting list on this strategy, so you can begin profiting immediately. In the coming months, we are adding more high-performance strategies without the liquidity limits on subscribers. Get registered to be notified when available, and check back often.
Limited Spots Available
Access is granted on a first-come, first-served basis, so secure your spot before the next weekly rebalance. This strategy is designed for investors with prior micro-cap experience. Depending on your portfolio size, you may need to scale your purchases and sales over time to ensure you don’t inadvertently move market prices against yourself. To help us manage liquidity and avoid overwhelming these microcap stocks with too much collective cash flow, please keep your portfolio size updated in your VitalQuant "My Profile" settings, linked in the footer.
Note: In the coming months, we are adding new high-return strategies without subscriber limits, so please stay informed by getting on the wait list if this model is closed.
Subscribe below
Monthly
Easy monthly billing. Sorry, but there is no free trial with this strategy.
$1,997
/month
Quarterly
Save 10% with a quarterly subscription. Sorry, no free trial with this model.
$5,392
/quarter
-10% discount
Annually
Save 20% with an annual subscription. Sorry, no free trial with this model.
$19,171
/year
-20% discount
Important Disclosures: For informational purposes only. VitalQuant does not offer personalized investment advice. Neither VitalQuant.com/VitalQuantitative Research, LLC, nor its employees, service providers, associates, or affiliates are responsible for any losses you may incur as a result of using the information provided. Investing in publicly traded securities is inherently risky, and you may lose money. Past investment performance may not be indicative of future returns. All quantitative strategies developed by any provider must use simulated or hypothetical performance results, which have inherent limitations and do not represent actual trading. All VitalQuant Strategies must have at least 5 years of out-of-sample, live performance. The content herein may not be copied, reproduced, or distributed in any way. See all Terms and Conditions for use of this website.
VitalQuant provides individual investors with institutional-grade investment strategy signals at an affordable price. Profit from Wall Street institutional-grade strategies today.
.svg)
.svg)
.svg)
.svg)